An overall feel about Praxis Precision Medicines Inc. (NASDAQ: PRAX) stock in the current moment?

The closing price of Praxis Precision Medicines Inc. (NASDAQ: PRAX) was $1.10 for the day, up 3.77% from the previous closing price of $1.06. In other words, the price has increased by $+0.0400 from its previous closing price. On the day, 1643539 shares were traded. PRAX stock price reached its highest trading level at $1.1400 during the session, while it also had its lowest trading level at $1.0201.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



Our analysis of PRAX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 3.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 24 when MITCHELL DEAN J bought 50,000 shares for $0.84 per share. The transaction valued at 41,815 led to the insider holds 75,000 shares of the business.

Souza Marcio bought 35,002 shares of PRAX for $30,207 on Mar 23. The Chief Executive Officer now owns 35,002 shares after completing the transaction at $0.86 per share. On Mar 23, another insider, Souza Marcio, who serves as the Chief Executive Officer of the company, bought 35,000 shares for $0.86 each. As a result, the insider paid 30,160 and bolstered with 226,299 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRAX now has a Market Capitalization of 62.60M and an Enterprise Value of -34.39M. For the stock, the TTM Price-to-Sale (P/S) ratio is 94.74 while its Price-to-Book (P/B) ratio in mrq is 0.91. Its current Enterprise Value per Revenue stands at -50.35 whereas that against EBITDA is 0.19.

Stock Price History:

Over the past 52 weeks, PRAX has reached a high of $10.88, while it has fallen to a 52-week low of $0.79. The 50-Day Moving Average of the stock is 0.9997, while the 200-Day Moving Average is calculated to be 2.3667.

Shares Statistics:

PRAX traded an average of 1.64M shares per day over the past three months and 871.68k shares per day over the past ten days. A total of 53.10M shares are outstanding, with a floating share count of 46.80M. Insiders hold about 0.60% of the company’s shares, while institutions hold 90.30% stake in the company. Shares short for PRAX as of Apr 27, 2023 were 5.01M with a Short Ratio of 5.01M, compared to 5.97M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 8.65% and a Short% of Float of 8.70%.

Earnings Estimates

The firm’s stock currently is rated by 4 analysts. On average, analysts expect EPS of -$0.68 for the current quarter, with a high estimate of -$0.6 and a low estimate of -$0.74, while EPS last year was -$1.32. The consensus estimate for the next quarter is -$0.67, with high estimates of -$0.61 and low estimates of -$0.71.

Analysts are recommending an EPS of between -$2.53 and -$2.85 for the fiscal current year, implying an average EPS of -$2.67. EPS for the following year is -$2.36, with 4 analysts recommending between -$1.94 and -$2.96.